Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee.

NCT03988023 is registered in ClinicalTrials.gov with Ampio Pharmaceuticals. Inc. as lead sponsor.

NCT NCT03988023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03988023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee.
Lead sponsor
Ampio Pharmaceuticals. Inc.
Phase
Phase 3
Overall status
Terminated
Start date
June 24, 2019
Completion date
July 13, 2021
Enrollment
1,043 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe osteoarthritis of the knee